ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 49 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,371,397 | +7.6% | 403,253 | +3.1% | 0.00% | – |
Q2 2023 | $5,922,632 | +532.5% | 391,191 | +505.8% | 0.00% | – |
Q1 2023 | $936,367 | -46.3% | 64,577 | -50.0% | 0.00% | – |
Q4 2022 | $1,744,702 | +232.3% | 129,046 | +287.6% | 0.00% | – |
Q3 2022 | $525,000 | +42.7% | 33,294 | +10.3% | 0.00% | – |
Q2 2022 | $368,000 | -74.1% | 30,194 | -80.0% | 0.00% | – |
Q1 2022 | $1,420,000 | +2.2% | 151,194 | +86.4% | 0.00% | – |
Q4 2021 | $1,389,000 | – | 81,119 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 509,023 | $8,042,563 | 53.88% |
MPM ASSET MANAGEMENT LLC | 4,425,784 | $69,927,387 | 37.45% |
5AM Venture Management, LLC | 4,408,379 | $69,652,388 | 20.04% |
StepStone Group LP | 761,277 | $12,028,177 | 2.68% |
TCG Crossover Management, LLC | 584,955 | $9,242,289 | 1.36% |
Redmile Group, LLC | 1,284,000 | $20,287,200 | 0.96% |
Nan Fung Group Holdings Ltd | 49,082 | $775,496 | 0.63% |
Baker Brothers Advisors | 4,865,819 | $76,879,940 | 0.44% |
Corton Capital Inc. | 10,485 | $165,663 | 0.08% |
CORNERCAP INVESTMENT COUNSEL INC | 13,977 | $220,837 | 0.04% |